Biotech Clinuvel Pharmaceuticals now expanding UV research
MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to $27.83 this
MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to $27.83 this
FEATURED
Boomer apartment plan splits public opinion into camps
Tropical oasis offers sanctuary from the troubles of ageing
Business investor went from hospital to helping others
How value-based care is changing operations in assisted living sector
Blood test may revolutionise how signs of Alzheimer’s are spotted
Architects designs stepped senior housing to “balance togetherness with independence”
INNOVATION
